RetinalGenix Technologies (RTGN) Share-based Compensation (QoQ) (2021 - 2026)
RetinalGenix Technologies (RTGN) Share-based Compensation (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.44% |
| Dec 31, 2025 | 1.45% |
| Sep 30, 2025 | 10.81% |
| Jun 30, 2025 | 7.87% |
| Mar 31, 2025 | -89.78% |
| Dec 31, 2024 | 665.83% |
| Sep 30, 2024 | 40.40% |
| Jun 30, 2024 | -87.82% |
| Mar 31, 2024 | 243.55% |
| Dec 31, 2023 | 17.66% |
| Sep 30, 2023 | 446.03% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -86.61% |
| Dec 31, 2022 | 729.51% |
| Sep 30, 2022 | 28.41% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -36.23% |
| Jun 30, 2021 | -22.57% |